FDA Approves Once-A-Day Lamictal XR as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures
Links shared publicly online about this topic.
- 1,393total visits
FDA Approves Once-A-Day Lamictal XR as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures
Lamictal XR (lamotrigine) is used for add-on epilepsy therapy for primary generalized tonic-clonic seizures. Includes Lamictal XR side effects, interactions and indications.
View full resource at drugs.com
Tags: Seizure, Seizure Medication, Epilepsy, FDA, Lamictal, Epilepsy Medication
Most Recently Shared on February 10, 2010 at 12:34 am By:
FDA Approves Lamictal XR as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures - http://bit.ly/aWlgPh
Advertisement
